Paclibenz 100 Injection
Marketer
Admac Pharma Ltd
Salt Composition
Paclitaxel (6mg/ml)
Overview Paclibenz 100 Injection
Oncaspar 100 Injection is a chemotherapy agent indicated for treating breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may vary. Strict adherence to your doctor's prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under your doctor's guidance. Typical side effects include nausea, vomiting, and fatigue; more serious reactions such as edema (hand and lip swelling), alopecia (hair loss), and weight increase are possible. Your doctor might prescribe additional medication to mitigate these effects. Report any unusual bruising or bleeding, sore throat, mouth sores, or fever immediately. This medication can decrease blood cell counts (red and white), increasing infection risk. Regular blood tests monitoring blood cell levels and liver function are essential. Inform your physician of any pre-existing heart, liver, or kidney conditions, or concurrent use of anti-infectives before commencing treatment. Interactions with other medications are possible; disclose all medications to your doctor. This medication is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is mandatory throughout treatment.
Uses of Paclibenz 100 Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of Paclibenz 100 Injection:
This medication will be administered by your physician or their qualified associate; self-medication is strictly prohibited.
Common Side effects of Paclibenz 100 Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Paclibenz 100 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Paclibenz 100 Injection works:
Paclibenz 100 Injection is a cancer treatment that disrupts microtubule function, essential for cancer cell division and proliferation. This action inhibits cancer cell growth, ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Paclibenz 100 Injection poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Administering Paclibenz 100 Injection during pregnancy poses a confirmed risk to the fetus and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider prescribing it if the potential advantages outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administering Paclibenz 100 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Paclibenz 100 Injection may induce adverse reactions that could impair driving ability. While driving between treatment cycles isn't inherently prohibited, consider that the medication includes alcohol, potentially making driving inadvisable.
KidneySAFE IF PRESCRIBED
Paclibenz 100 Injection poses no safety concerns for individuals with impaired renal function; dosage modification is unnecessary. Nevertheless, consultation with a physician is advised for patients with pre-existing kidney conditions.
LiverCAUTION
Administering Paclibenz 100 Injection to individuals with hepatic impairment requires careful consideration. Dosage modification for Paclibenz 100 Injection might be necessary. Physician consultation is advised. Paclibenz 100 Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Paclibenz 100 Injection :
NA
Facts to Know About Paclibenz 100 Injection
| Label | Value |
|---|---|
| Type of Compound | Taxane-based medications |
| Potential for Dependence | None. |
| Medication Classification | Cancer therapeutics |
| Mechanism of Action | Microtubule-targeting drugs: Taxanes |
3,018 People bought this recently